[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"fda-warning-letters-search:[\"Associates of Cape Cod, Inc.\",\"\",\"\",\"\",\"\",1]":3,"fda-latest-sync-dates":57},{"warningLetters":4,"total":56},[5,33],{"id":6,"raw":7,"subject":12,"body_html":15,"body_text":16,"firm_name":17,"letter_id":18,"created_at":19,"fei_number":20,"letter_url":21,"updated_at":22,"action_type":23,"case_status":24,"posted_date":25,"marcs_cms_no":26,"product_type":27,"closeout_date":28,"issuing_office":11,"recipient_name":29,"body_fetched_at":30,"delivery_method":31,"recipient_title":20,"reference_number":20,"action_taken_date":32,"medical_device_id":20,"response_letter_date":20},3233,[8,9,10,11,12,13,14,13],"\u003Ctime datetime=\"2021-08-03T13:20:00Z\">08\u002F03\u002F2021\u003C\u002Ftime>\n","\u003Ctime datetime=\"2021-07-20T04:00:00Z\">07\u002F20\u002F2021\u003C\u002Ftime>\n","\u003Ca href=\"\u002Finspections-compliance-enforcement-and-criminal-investigations\u002Fwarning-letters\u002F2m-associates-inc-614195-07202021\">2m Associates, Inc.\u003C\u002Fa>","Division of Northeast Imports","Foreign Supplier Verification Program (FSVP)","","\u003Ca href=\"\u002Finspections-compliance-enforcement-and-criminal-investigations\u002Fwarning-letters\u002F2m-associates-inc-614195-04122022\">\u003Ctime datetime=\"2022-04-19T04:00:00Z\">04\u002F19\u002F2022\u003C\u002Ftime>\n\u003C\u002Fa>","\n\n                            \n                            \n                            \n                            \n                                              \n  \n \n\n                 \n\n  \u003Chr>\n \n\n\u003Cdiv>\n  \u003Cdl>\n\n              \u003Cdt>Delivery Method:\u003C\u002Fdt> \n        \u003Cdd>VIA UNITED PARCEL SERVICE\n                                                                                                                                                                                                                                                                                                                                                                                                                              \u003C\u002Fdd>\n      \n      \n              \u003Cdt>Product:\u003C\u002Fdt> \n        \u003Cdd>Food &amp; Beverages                          \n            \n            \n            \n            \n            \n            \n            \n             \n            \n            \n            \n              \n            \n            \n            \u003C\u002Fdd>\n      \n          \u003C\u002Fdl>\n  \u003C\u002Fdiv>            \n\n\n\u003Chr>\n\n\u003Cdiv>\n  \u003Cdiv>\n    \u003Cdl>\n\n        \u003Cdt>Recipient:\u003C\u002Fdt>\n\n                      \u003Cdd>\n  \u003Cdiv>\n    \u003Cdiv>Recipient Name\u003C\u002Fdiv>\n              \u003Cdiv>Mr. Alpha Bah\u003C\u002Fdiv>\n          \u003C\u002Fdiv>\n\u003C\u002Fdd>\n                                \u003Cdd>\n  \u003Cdiv>\n    \u003Cdiv>Recipient Title\u003C\u002Fdiv>\n              \u003Cdiv>C.E.O. and Owner\u003C\u002Fdiv>\n          \u003C\u002Fdiv>\n\u003C\u002Fdd>\n          \n            \u003Cdd>2m Associates, Inc.\u003C\u002Fdd>\n\n          \n                      \u003Cdd>\u003Cp>\u003Cspan>203 W. 140th St, Apt. 4C\u003C\u002Fspan>\u003Cbr>\n\u003Cspan>New York\u003C\u002Fspan>, \u003Cspan>NY\u003C\u002Fspan> \u003Cspan>10030\u003C\u002Fspan>\u003Cbr>\n\u003Cspan>United States\u003C\u002Fspan>\u003C\u002Fp>\u003C\u002Fdd>\n          \n          \n          \n    \u003C\u002Fdl>\n  \u003C\u002Fdiv>            \n\n       \u003Cdiv>\n    \u003Cdl>\n          \n          \u003Cdt>Issuing Office:\u003C\u002Fdt>\n        \n         \n          \u003Cdd>Division of Northeast Imports\u003C\u002Fdd>\n        \n         \n          \u003Cdd>\u003Cp>\u003Cspan>United States\u003C\u002Fspan>\u003C\u002Fp>\u003C\u002Fdd>\n        \n        \n        \n        \n        \n    \u003C\u002Fdl>\n    \u003Cdl> \n      \n    \u003C\u002Fdl>\n  \u003C\u002Fdiv>  \n      \n\u003C\u002Fdiv>\n\n \n\n \n\n\u003Chr>\n\n\u003Cp>\u003Cstrong>WARNING LETTER\u003Cbr>\nCMS # 614195\u003C\u002Fstrong>\u003C\u002Fp>\n\n\u003Cp>Date: 7\u002F20\u002F2021\u003C\u002Fp>\n\n\u003Cp>Dear Mr. Bah:\u003C\u002Fp>\n\n\u003Cp>On February 1, 2021 through March 3, 2021, the Food and Drug Administration (FDA) conducted a remote Foreign Supplier Verification Program (FSVP) inspection of 2m Associates Inc. located at 523 Casanova Street, Bronx, NY 10474. We also conducted an initial inspection on April 12, 2019. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1 subpart L.\u003C\u002Fp>\n\n\u003Cp>The FSVP regulation requires that importers perform certain risk-based activities to verify that human and\u002For animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at \u003Ca href=\"https:\u002F\u002Fwww.fda.gov\u002Ffood\u002Ffood-safety-modernization-act-fsma\u002Ffsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals\">https:\u002F\u002Fwww.fda.gov\u002Ffood\u002Ffood-safety-modernization-act-fsma\u002Ffsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals\u003C\u002Fa>.\u003C\u002Fp>\n\n\u003Cp>During the inspection, we found that you were not in compliance with the requirements of 21 CFR part 1 subpart L for your \u003Cstrong>(b)(4)\u003C\u002Fstrong>&nbsp;broken rice and \u003Cstrong>(b)(4)&nbsp;\u003C\u002Fstrong>rice imported from \u003Cstrong>(b)(4)\u003C\u002Fstrong>, located in \u003Cstrong>(b)(4)\u003C\u002Fstrong>. Your firm did not have FSVPs for these foods. Because of this significant violation, you are not in compliance with section 805 of the FD&amp;C Act.\u003C\u002Fp>\n\n\u003Cp>At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations.\u003C\u002Fp>\n\n\u003Cp>As of the date of this letter, we have not received your response to the Form FDA 483a issued on March 3, 2021.\u003C\u002Fp>\n\n\u003Cp>Your significant violation of the FSVP regulation is as follows:\u003C\u002Fp>\n\n\u003Cp>You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&amp;C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for each of the following foods:\u003Cbr>\n• \u003Cstrong>(b)(4)\u003C\u002Fstrong> broken rice imported from \u003Cstrong>(b)(4)\u003C\u002Fstrong>, located in \u003Cstrong>(b)(4)\u003C\u002Fstrong>.\u003Cbr>\n• \u003Cstrong>(b)(4)\u003C\u002Fstrong> rice imported from \u003Cstrong>(b)(4)\u003C\u002Fstrong>, located in \u003Cstrong>(b)(4)\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\u003Cp>The above is not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&amp;C Act and the implementing regulation in 21 CFR part 1 subpart L.\u003C\u002Fp>\n\n\u003Cp>This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in further action. For instance, we may take action under section 801(a)(3) of the FD&amp;C Act (21 U.S.C. 381(a)(3)) to refuse admission of \u003Cstrong>(b)(4)\u003C\u002Fstrong> broken rice and \u003Cstrong>(b)(4)\u003C\u002Fstrong> rice imported from \u003Cstrong>(b)(4)\u003C\u002Fstrong>, located in \u003Cstrong>(b)(4)\u003C\u002Fstrong>. We may place the food you import from the identified foreign supplier on detention without physical examination (DWPE) when you import the foods. You can find DWPE information relating to FSVP in Import Alert # 99-41 at \u003Ca href=\"http:\u002F\u002Fwww.accessdata.fda.gov\u002Fcms_ia\u002Fialist.html\">http:\u002F\u002Fwww.accessdata.fda.gov\u002Fcms_ia\u002Fialist.html\u003C\u002Fa>. In addition, the importation or offering for importation into the United States of an article of food without the importer having an FSVP that meets the requirements of section 805 of the FD&amp;C Act or the FSVP regulation is prohibited under section 301(zz) of the FD&amp;C Act.\u003C\u002Fp>\n\n\u003Cp>You should respond in writing to the FSVP violations within fifteen (15) working days from your receipt of this letter. Your response should address the specific things you are doing to correct these violations. You should include in your response documentation and information that will assist us in evaluating your corrections, (e.g., documentation of changes you made, such as a copy of your FSVP, records to demonstrate implementation of your FSVP), and any additional information that you wish to supply relevant to your compliance with the FSVP regulation. If you believe that you are not in violation of the FD&amp;C Act, include your reasoning and any supporting information for our consideration. If you cannot complete all corrections within 15 days, you should explain the reason for your delay and state when you will correct any remaining violations.\u003C\u002Fp>\n\n\u003Cp>Please send your reply to Food and Drug Administration, Attention: Linda Ross, FDA Compliance Officer; Division of Northeast Imports: ORAOEIONEIMPORTSWLResponses@fda.hhs.gov. Please also cc (carbon copy) linda.ross@fda.hhs.gov. If you have any questions regarding this letter, you may contact Compliance Officer Ross via email at linda.ross@fda.hhs.gov. Please reference CMS # 614195 on any documents or records you provide to us and\u002For within the subject line of any email correspondence you send to us.\u003C\u002Fp>\n\n\u003Cp>Sincerely,\u003Cbr>\n\u002FS\u002F\u003C\u002Fp>\n\n\u003Cp>Dawne Hines\u003Cbr>\nProgram Division Director\u003Cbr>\nDivision of Northeast Imports\u003C\u002Fp>\n\n\n\n\n\n\n\n              \n                                            \n              \n            ","Delivery Method:\n\nVIA UNITED PARCEL SERVICE\n\nProduct:\n\nFood & Beverages\n\nRecipient:\n\nRecipient Name\n\nMr. Alpha Bah\n\nRecipient Title\n\nC.E.O. and Owner\n\n2m Associates, Inc.\n\n203 W. 140th St, Apt. 4C\n\nNew York, NY 10030\n\nUnited States\n\nIssuing Office:\n\nDivision of Northeast Imports\n\nUnited States\n\nWARNING LETTER\n\nCMS # 614195\n\nDate: 7\u002F20\u002F2021\n\nDear Mr. Bah:\n\nOn February 1, 2021 through March 3, 2021, the Food and Drug Administration (FDA) conducted a remote Foreign Supplier Verification Program (FSVP) inspection of 2m Associates Inc. located at 523 Casanova Street, Bronx, NY 10474. We also conducted an initial inspection on April 12, 2019. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1 subpart L.\n\nThe FSVP regulation requires that importers perform certain risk-based activities to verify that human and\u002For animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https:\u002F\u002Fwww.fda.gov\u002Ffood\u002Ffood-safety-modernization-act-fsma\u002Ffsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals.\n\nDuring the inspection, we found that you were not in compliance with the requirements of 21 CFR part 1 subpart L for your (b)(4) broken rice and (b)(4) rice imported from (b)(4), located in (b)(4). Your firm did not have FSVPs for these foods. Because of this significant violation, you are not in compliance with section 805 of the FD&C Act.\n\nAt the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations.\n\nAs of the date of this letter, we have not received your response to the Form FDA 483a issued on March 3, 2021.\n\nYour significant violation of the FSVP regulation is as follows:\n\nYou did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for each of the following foods:\n\n• (b)(4) broken rice imported from (b)(4), located in (b)(4).\n\n• (b)(4) rice imported from (b)(4), located in (b)(4).\n\nThe above is not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1 subpart L.\n\nThis letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in further action. For instance, we may take action under section 801(a)(3) of the FD&C Act (21 U.S.C. 381(a)(3)) to refuse admission of (b)(4) broken rice and (b)(4) rice imported from (b)(4), located in (b)(4). We may place the food you import from the identified foreign supplier on detention without physical examination (DWPE) when you import the foods. You can find DWPE information relating to FSVP in Import Alert # 99-41 at http:\u002F\u002Fwww.accessdata.fda.gov\u002Fcms_ia\u002Fialist.html. In addition, the importation or offering for importation into the United States of an article of food without the importer having an FSVP that meets the requirements of section 805 of the FD&C Act or the FSVP regulation is prohibited under section 301(zz) of the FD&C Act.\n\nYou should respond in writing to the FSVP violations within fifteen (15) working days from your receipt of this letter. Your response should address the specific things you are doing to correct these violations. You should include in your response documentation and information that will assist us in evaluating your corrections, (e.g., documentation of changes you made, such as a copy of your FSVP, records to demonstrate implementation of your FSVP), and any additional information that you wish to supply relevant to your compliance with the FSVP regulation. If you believe that you are not in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. If you cannot complete all corrections within 15 days, you should explain the reason for your delay and state when you will correct any remaining violations.\n\nPlease send your reply to Food and Drug Administration, Attention: Linda Ross, FDA Compliance Officer; Division of Northeast Imports: ORAOEIONEIMPORTSWLResponses@fda.hhs.gov. Please also cc (carbon copy) linda.ross@fda.hhs.gov. If you have any questions regarding this letter, you may contact Compliance Officer Ross via email at linda.ross@fda.hhs.gov. Please reference CMS # 614195 on any documents or records you provide to us and\u002For within the subject line of any email correspondence you send to us.\n\nSincerely,\n\n\u002FS\u002F\n\nDawne Hines\n\nProgram Division Director\n\nDivision of Northeast Imports","2m Associates, Inc.","2m-associates-inc-614195-07202021","2026-08-18T06:42:29.386127+00:00",null,"https:\u002F\u002Fwww.fda.gov\u002Finspections-compliance-enforcement-and-criminal-investigations\u002Fwarning-letters\u002F2m-associates-inc-614195-07202021","2026-10-26T08:07:47.610977+00:00","Warning Letter","Closed Out","2021-08-03","614195","Food & Beverages","2022-04-19","Mr. Alpha Bah","2026-08-20T02:43:53.314+00:00","VIA UNITED PARCEL SERVICE","2021-07-20",{"id":34,"raw":35,"subject":41,"body_html":42,"body_text":43,"firm_name":44,"letter_id":45,"created_at":46,"fei_number":20,"letter_url":47,"updated_at":48,"action_type":23,"case_status":49,"posted_date":50,"marcs_cms_no":51,"product_type":27,"closeout_date":20,"issuing_office":39,"recipient_name":52,"body_fetched_at":53,"delivery_method":54,"recipient_title":20,"reference_number":20,"action_taken_date":55,"medical_device_id":20,"response_letter_date":20},565,[36,37,38,39,40,13,13,13],"\u003Ctime datetime=\"2025-09-30T04:00:00Z\">09\u002F30\u002F2025\u003C\u002Ftime>\n","\u003Ctime datetime=\"2025-08-21T04:00:00Z\">08\u002F21\u002F2025\u003C\u002Ftime>\n","\u003Ca href=\"\u002Finspections-compliance-enforcement-and-criminal-investigations\u002Fwarning-letters\u002Fnestor-reyes-farm-associates-701874-08212025\">Nestor Reyes Farm &amp; Associates\u003C\u002Fa>","Human Foods Program","PHS Act\u002FShell Egg Regulation\u002FAdulterated ","PHS Act\u002FShell Egg Regulation\u002FAdulterated","\n\n                            \n                            \n                            \n                            \n                                              \n  \n \n\n                 \n\n  \u003Chr>\n \n\n\u003Cdiv>\n  \u003Cdl>\n\n              \u003Cdt>Delivery Method:\u003C\u002Fdt> \n        \u003Cdd>Via Email\n                                                                                                                                                                                                                                                                                                                                                                                                                              \u003C\u002Fdd>\n      \n      \n              \u003Cdt>Product:\u003C\u002Fdt> \n        \u003Cdd>Food &amp; Beverages                          \n            \n            \n            \n            \n            \n            \n            \n             \n            \n            \n            \n              \n            \n            \n            \u003C\u002Fdd>\n      \n          \u003C\u002Fdl>\n  \u003C\u002Fdiv>            \n\n\n\u003Chr>\n\n\u003Cdiv>\n  \u003Cdiv>\n    \u003Cdl>\n\n        \u003Cdt>Recipient:\u003C\u002Fdt>\n\n                      \u003Cdd>\n  \u003Cdiv>\n    \u003Cdiv>Recipient Name\u003C\u002Fdiv>\n              \u003Cdiv>Mr. Nestor E. Reyes del Valle\u003C\u002Fdiv>\n          \u003C\u002Fdiv>\n\u003C\u002Fdd>\n                                \u003Cdd>\n  \u003Cdiv>\n    \u003Cdiv>Recipient Title\u003C\u002Fdiv>\n              \u003Cdiv>President \u003C\u002Fdiv>\n          \u003C\u002Fdiv>\n\u003C\u002Fdd>\n          \n            \u003Cdd>Nestor Reyes Farm &amp; Associates\u003C\u002Fdd>\n\n          \n                      \u003Cdd>\u003Cp>\u003Cspan>Rd. 956, Km 10.0, Bo. Guzman Arriba\u003C\u002Fspan>\u003Cbr>\n\u003Cspan>Rio Grande\u003C\u002Fspan> \u003Cspan>00745\u003C\u002Fspan>\u003Cbr>\n\u003Cspan>Puerto Rico\u003C\u002Fspan>\u003C\u002Fp>\u003C\u002Fdd>\n          \n          \n          \n    \u003C\u002Fdl>\n  \u003C\u002Fdiv>            \n\n       \u003Cdiv>\n    \u003Cdl>\n          \n          \u003Cdt>Issuing Office:\u003C\u002Fdt>\n        \n         \n          \u003Cdd>Human Foods Program\u003C\u002Fdd>\n        \n         \n          \u003Cdd>\u003Cp>\u003Cspan>United States\u003C\u002Fspan>\u003C\u002Fp>\u003C\u002Fdd>\n        \n        \n        \n        \n        \n    \u003C\u002Fdl>\n    \u003Cdl> \n      \n    \u003C\u002Fdl>\n  \u003C\u002Fdiv>  \n      \n\u003C\u002Fdiv>\n\n \n\n \n\n\u003Chr>\n\n\u003Cp>\u003Cstrong>WARNING LETTER\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>August 21, 2025\u003C\u002Fp>\u003Cp>CMS #701874\u003C\u002Fp>\u003Cp>Dear Mr. Nestor E. Reyes del Valle:\u003C\u002Fp>\u003Cp>On November 13-15 &amp; 19, 2024, and December 6, 2024, the United States Food and Drug Administration (FDA) conducted an inspection of your shell egg farm and egg processing facility, where your shell eggs are washed and packed, located at Rd. 956, Km 10.0, Bo. Guzman Arriba, Rio Grande, PR 00745. During the inspection of your farm, FDA investigators observed serious violations of the Prevention of Salmonella Enteritidis (SE) in Shell Eggs During Production, Storage, and Transportation regulation (the Shell Egg regulation), Title 21, Code of Federal Regulations, Part 118 (21 CFR Part 118). At the conclusion of the inspection, FDA investigators issued an FDA Form 483 (FDA-483), Inspectional Observations, listing deviations found at your farm.\u003C\u002Fp>\u003Cp>Based on FDA’s inspectional findings, we have determined that the shell eggs produced on your farm do not comply with the provisions of 21 CFR Part 118. Failure to comply with the provisions of 21 CFR Part 118 causes your shell eggs to be in violation of section 361(a) of the Public Health Service Act (the PHS Act), 42 U.S.C. § 264(a). In addition, these violations render your shell eggs adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the FD&amp;C Act), 21 U.S.C. § 342(a)(4), in that they have been prepared, packed, or held under insanitary conditions whereby they may have become contaminated with filth, or whereby they may have been rendered injurious to health. You may find the FD&amp;C Act, the PHS Act and the Shell Egg regulation through links on FDA’s home page at www.fda.gov.\u003C\u002Fp>\u003Cp>We received your response to the FDA-483 via email on December 20, 2024, which described corrective actions taken or planned by your farm. Based on our review of the inspectional findings and your response, we are issuing this letter to advise you of FDA’s continuing concerns and to provide detailed information describing the findings at your farm.\u003C\u002Fp>\u003Cp>Your significant violations are as follows:\u003C\u002Fp>\u003Cp>\u003Cu>Shell Egg Regulation (21 CFR Part 118)\u003C\u002Fu>\u003C\u002Fp>\u003Cp>1. You did not have and implement a written SE Prevention Plan that includes, at a minimum, the SE prevention measures required by 21 CFR 118.4. You did not have a written SE Prevention Plan for the approximate \u003Cstrong>(b)(4)\u003C\u002Fstrong> layers on your farm. Your written response stated that an SE Prevention Plan would be finalized between December 2024 and January 2025. To date, we have not received a written SE Prevention Plan. You are required to have an SE Prevention Plan that includes, at a minimum, the SE prevention measures outlined in 21 CFR 118.4 (a) – (e), which include:\u003C\u002Fp>\u003Cp>a. \u003Cu>Pullets\u003C\u002Fu>\u003Cbr>A written SE Prevention Plan must include, among other things, the required SE prevention measures relating to pullets. Under 21 CFR 118.4(a), these measures include procuring pullets that are SE monitored or raising pullets under SE monitored conditions. Under 21 CFR 118.4(a)(1), “SE monitored” means that chicks are procured from SE-monitored breeder flocks that meet the National Poultry Improvement Plan’s (NPIP) standards for “U.S. S. Enteritidis Clean” status (9 CFR 145.23(d)) or an equivalent standard. Under 21 CFR 118.4(a)(2), “SE monitored” also means that the pullet environment is tested for SE when pullets are 14-16 weeks of age.\u003C\u002Fp>\u003Cp>Your farm received a primary flock of \u003Cstrong>(b)(4)\u003C\u002Fstrong> chicks on April 30, 2024, followed by a secondary flock of \u003Cstrong>(b)(4)\u003C\u002Fstrong> chicks on May 7, 2024. We acknowledge you provided a NPIP Form for the flock of chicks you procured from your supplier on May 7, 2024, but you did not provide documentation for the chicks received on or around April 30, 2024. Furthermore, you did not conduct the required SE environmental test for both flocks at 14-to-16 weeks of age, as required by 21 CFR 118.4(a)(2)(i).\u003C\u002Fp>\u003Cp>Your written response stated that you will schedule for future flocks to be tested for SE between 14-16 weeks of age by a licensed professional. However, as discussed above, we have not received a written SE Prevention Plan that describes these measures. We also note that your written response stated, as part of your firm’s corrective actions, that FDA swabbed poultry house \u003Cstrong>(b)(4)\u003C\u002Fstrong> on November 19, 2024, with subsequent negative results. The layers were approximately \u003Cstrong>(b)(4)\u003C\u002Fstrong> weeks of age when FDA conducted this sampling. This does not constitute a corrective action and should not be viewed as suc\u003Ca>h.\u003C\u002Fa>\u003C\u002Fp>\u003Cp>b. \u003Cu>Biosecurity\u003C\u002Fu>\u003Cbr>A written SE Prevention Plan must include, among other things, the required SE prevention measures relating to biosecurity, as stated in 21 CFR 118.4(b). That provision requires you to take steps to ensure that there is no introduction or transfer of SE into or among poultry houses. These biosecurity measures must include, at a minimum:\u003C\u002Fp>\u003Cul>\u003Cli>Limiting visitors on the farm and in the poultry houses (21 CFR 118.4(b)(1));\u003C\u002Fli>\u003Cli>Maintaining practices that will protect against cross contamination when equipment is moved among poultry houses (21 CFR 118.4(b)(2));\u003C\u002Fli>\u003Cli>Maintaining practices that will protect against cross contamination when persons move between poultry houses (21 CFR 118.4(b)(3));\u003C\u002Fli>\u003Cli>Preventing stray poultry, wild birds, cats, and other animals from entering poultry houses (21 CFR 118.4(b)(4)); and\u003C\u002Fli>\u003Cli>Not allowing employees to keep birds at home (21 CFR 118.4(b)(5)).\u003C\u002Fli>\u003C\u002Ful>\u003Cp>As discussed above, you did not have a written SE Prevention Plan to address these measures. Furthermore, visitors’ access to the facility was not limited and, despite your indication on November 13, 2024, that individuals enter the facility to pick up or distribute eggs every other day, our investigators identified August 20, 2024, as the last date a pickup was registered in your entry log. Additionally, for poultry house \u003Cstrong>(b)(4)\u003C\u002Fstrong>, FDA investigators observed there was no entry door to limit access and the house had damaged or missing netting and gaps within the cement structure. Numerous wild birds located inside the poultry house above layers in cages, in walkways, and eating directly from feed trays. Wild birds were also observed in the manure pits, and along the perimeter of your exposed house. Furthermore, cats and several species of reptiles were also observed in the manure pit and surrounding the poultry house.\u003C\u002Fp>\u003Cp>We acknowledge your written response, in which you state you are now restricting visitor access to the farm through signs, and that you have implemented a visitor log and provided employee training. You also described how you will prevent stray animals from entering the poultry houses by adding physical barriers. You state your poultry houses are under construction, which you expect to be completed by June 2025. However, your written response lacks supporting detail to further assess how you will implement these corrective actions and practices. Additionally, you did not provide an SE Prevention Plan to describe any biosecurity steps.\u003C\u002Fp>\u003Cp>c. \u003Cu>Rodents, Flies, and Other Pest Control\u003C\u002Fu>\u003Cbr>A written SE Prevention Plan must include, among other things, the required rodent, fly, and other pest control measures as stated in 21 CFR 118.4(c). As discussed above, you did not have a written SE Prevention Plan to address these measures. Furthermore, you were not monitoring for the presence of rodents and flies by appropriate monitoring methods, as required by 21 CFR 118.4(c)(1) and 21 CFR 118.4(c)(2), nor did you remove debris within a poultry house and vegetation and debris outside the poultry house that may provide harborage for pests, as required by 21 CFR 118.4(c)(3).\u003C\u002Fp>\u003Cp>Specifically, for rodents, you stated you receive monthly services by a subcontractor; however, there were no pest control records available for review. Additionally, FDA investigators observed multiple rodent bait stations for poultry house \u003Cstrong>(b)(4)\u003C\u002Fstrong> that were broken and\u002For did not contain bait. For flies, you did not have any monitoring or control measures in place, and FDA investigators also observed flies too numerous to count inside the poultry house that were in direct contact with hens, eggs, and chicken feed. Furthermore, FDA investigators observed harborage for pests in and outside of your poultry house. This included excessive amounts of accumulated trash and debris, stagnant water, piles of broken eggs, and spilled chicken feed. Also, multiple deceased layers were observed inside poultry house \u003Cstrong>(b)(4)\u003C\u002Fstrong>, with two of the deceased birds having their heads in direct contact with the egg belt, causing the eggs to get jammed.\u003C\u002Fp>\u003Cp>Your written response acknowledged that rodents were not being monitored appropriately and stated that the rodent monitoring and bait stations have been installed and updated, more rodent bait stations have been added around buildings, professional pest control services have been engaged, and that you have cleaned and removed debris that may attract rodents. Furthermore, your response acknowledged that the presence of flies was not being appropriately monitored and stated that fly monitoring systems have been updated. Additionally, you stated potential pest harborage sites inside and outside the poultry houses have been eliminated. However, your response did not provide an SE Prevention Plan or provide supporting details to assess whether the corrective actions were adequate. Please note that in addition to describing appropriate monitoring methods for rodents and flies, a written SE Prevention Plan must also address the requirement that when monitoring indicates unacceptable rodent or fly activity within a poultry house, you must use appropriate methods to achieve satisfactory rodent\u002Ffly control.\u003C\u002Fp>\u003Cp>d. \u003Cu>Cleaning and Disinfection\u003C\u002Fu>\u003Cbr>A written SE Prevention Plan must include, among other things, cleaning and disinfection procedures for the poultry house, as stated in 21 CFR 118.4(d). You must clean and disinfect the poultry house according to these procedures before new laying hens are added to the house, if you have had an environmental test or an egg test that was positive for SE at any point during the life of a flock that was housed in the poultry house prior to depopulation.\u003C\u002Fp>\u003Cp>As discussed above, you did not have a written SE Prevention Plan. Your written response states that you are developing a written SE Prevention Plan that will include, among other things, cleaning and disinfection protocols. However, as discussed above, you still have not provided a written SE Prevention Plan.\u003C\u002Fp>\u003Cp>e. \u003Cu>Refrigeration\u003C\u002Fu>\u003Cbr>You did not hold eggs at or below 45°F ambient temperature beginning 36 hours after time of lay, nor do you have a written SE Prevention Plan including these refrigeration requirements, as required by 21 CFR 118.4(e). For example:\u003C\u002Fp>\u003Cul>\u003Cli>On November 14, 2024, your two analog thermometers located at the back and entrance of the cooler read \u003Cstrong>(b)(4)\u003C\u002Fstrong>°-\u003Cstrong>(b)(4)\u003C\u002Fstrong>°F, while FDA’s calibrated thermometer read 52°-58°F. On November 14, 2024, the same two analog thermometers read between \u003Cstrong>(b)(4)\u003C\u002Fstrong>°-\u003Cstrong>(b)(4)\u003C\u002Fstrong>°F, while the FDA calibrated thermometer read 58.8°F.\u003C\u002Fli>\u003Cli>On November 15, 2024, your two thermometers at the entrance of the cooler read \u003Cstrong>(b)(4)\u003C\u002Fstrong>°F (digital) \u002F \u003Cstrong>(b)(4)\u003C\u002Fstrong>°F (analog), while the FDA calibrated thermometer read 46.5°F.\u003C\u002Fli>\u003Cli>On November 19, 2024, your two thermometers at the entrance of the cooler read \u003Cstrong>(b)(4)\u003C\u002Fstrong>°F (digital) \u002F \u003Cstrong>(b)(4)\u003C\u002Fstrong>°F (analog), while the FDA calibrated thermometer read 51.9°F\u003C\u002Fli>\u003C\u002Ful>\u003Cp>We acknowledge your written response, in which you state that “\u003Cstrong>(b)(4)\u003C\u002Fstrong>.” You stated \u003Cstrong>(b)(4)\u003C\u002Fstrong>. However, your response did not provide an SE Prevention Plan or provide supporting details to assess whether the corrective actions were adequate.\u003C\u002Fp>\u003Cp>2. You have never registered your egg farm with FDA, as required by 21 CFR 118.11(a).\u003C\u002Fp>\u003Cp>Your written response states that you registered your farm with FDA by December 6, 2024; however, we do not have a record of your registration.\u003C\u002Fp>\u003Cp>\u003Cu>Federal Food, Drug, and Cosmetic Act (FD&amp;C Act)\u003C\u002Fu>\u003C\u002Fp>\u003Cp>Your eggs were prepared, packed, or held under insanitary conditions whereby they may have become contaminated with filth or rendered injurious to health within the meaning of section 402(a)(4) of the FD&amp;C Act. Specifically, during the inspection, our investigators observed the following insanitary conditions and practices at your farm during the processing of shell eggs:\u003C\u002Fp>\u003Cul>\u003Cli>FDA investigators observed too numerous to count dead flies inside the \u003Cstrong>(b)(4)\u003C\u002Fstrong>-gallon water tank of the egg washer and lying on the surface of the egg washer. Flies were also observed inside the packaging room on top of washed eggs.\u003C\u002Fli>\u003Cli>The conveyor belt connecting poultry house \u003Cstrong>(b)(4)\u003C\u002Fstrong> to the egg washing\u002Fpackaging room was uncovered, outside of any building structure. FDA investigators observed that the eggs held on this conveyor belt are continuously exposed to the environment and to pests and other animals, including flying insects, reptiles, cats, and wild birds, for up to \u003Cstrong>(b)(4)\u003C\u002Fstrong> hours (because collection and packaging operations are conducted every other day\u003Ca>).\u003C\u002Fa>\u003C\u002Fli>\u003C\u002Ful>\u003Cp>Furthermore, you did not follow the disinfectant manufacturer’s instructions in preparing the disinfectant solution for the eggs by using the correct amount of disinfectant within the \u003Cstrong>(b)(4)\u003C\u002Fstrong>-gallon water tanks. You stated that \u003Cstrong>(b)(4)\u003C\u002Fstrong> oz. of disinfectant is used for the \u003Cstrong>(b)(4)\u003C\u002Fstrong>-gallon tank of the washing machine, instead of the 22.5 oz. directed by the manufacturer’s instructions of 0.5 oz per gallon.\u003C\u002Fp>\u003Cp>Your written response stated that a monitoring program has been established to inspect conveyor belts and poultry houses daily. Furthermore, you stated your employees were not properly trained on the manufacturer’s instructions for the appropriate level of disinfectant. As your corrective actions, you state you have retrained your employees on the proper preparation of the disinfectant and revised your procedures and displayed them near the egg washer. Furthermore, your written response stated you have cleaned the washer, have implemented a daily cleaning and inspection schedule to ensure consistent hygiene, and introduced a new maintenance log for documenting cleaning and sanitation activities. You have not provided additional supporting details in order for us to fully evaluate these corrective actions.\u003C\u002Fp>\u003Cp>This letter is not intended to be an all-inclusive statement of the violations that may exist at your farm or in connection with your shell eggs. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your shell egg production practices are conducted in compliance with federal law, including the FD&amp;C Act, the PHS Act, and the Shell Egg regulation.\u003C\u002Fp>\u003Cp>This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in legal action including, without limitation, seizure, injunction, or the initiation of administrative enforcement procedures under 21 CFR 118.12(a).\u003C\u002Fp>\u003Cp>\u003Cstrong>Additional Comment\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>Records are an important component to ensure your compliance with FDA’s Shell Egg regulation. 21 CFR 118.10 describes the records required for your SE Prevention Plan and other general recordkeeping requirements. We encourage you to review these requirements when working to develop and implement your SE Prevention Plan and environmental testing procedures. Please note that resources are also available on our website at www.fda.gov\u002Feggs that address various aspects of shell egg regulation, including some of the topics addressed in this letter. For example, the December 2011 Guidance for Industry “Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation” and the July 2015 Guidance for Industry “Questions and Answers Regarding the Final Rule, Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation” provide answers to common questions about the Shell Egg regulation.\u003C\u002Fp>\u003Cp>Please notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective actions within 15 working days, state the reason for the delay and the time within which you will do so. If you believe that you have complied with pertinent laws and regulations, include your reasoning and any supporting information for our consideration.\u003C\u002Fp>\u003Cp>Please send your reply via email to: HFP-OCE-ConventionalFoods@fda.hhs.gov, copying Lisa Thursam, Compliance Officer, at Lisa.Thursam@fda.hhs.gov or by hardcopy to Food and Drug Administration, Attention: Lisa Thursam, Compliance Officer, Human Foods Program – Office of Compliance and Enforcement, Office of Enforcement – Division of Conventional Foods Enforcement (HFS-607), 5001 Campus Drive, College Park, MD 20740 U.S.A. If you have any questions regarding any issues in this letter, please contact Lisa Thursam, Compliance Officer, via email at Lisa.Thursam@fda.hhs.gov. Please include CMS reference #701874 on any submissions and within the subject line of any email correspondence to the agency.\u003C\u002Fp>\u003Cp>Sincerely,\u003Cbr>\u002FS\u002F\u003C\u002Fp>\u003Cp>Maria S. Knirk, J.D., M.B.A.\u003Cbr>Acting Director, Office of Enforcement\u003Cbr>Office of Compliance and Enforcement\u003Cbr>Human Foods Program\u003Cbr>Food and Drug Administration\u003C\u002Fp>\n\n\n\n\n\n\n              \n                                            \n              \n            ","Delivery Method:\n\nVia Email\n\nProduct:\n\nFood & Beverages\n\nRecipient:\n\nRecipient Name\n\nMr. Nestor E. Reyes del Valle\n\nRecipient Title\n\nPresident\n\nNestor Reyes Farm & Associates\n\nRd. 956, Km 10.0, Bo. Guzman Arriba\n\nRio Grande 00745\n\nPuerto Rico\n\nIssuing Office:\n\nHuman Foods Program\n\nUnited States\n\nWARNING LETTER\nAugust 21, 2025\nCMS #701874\nDear Mr. Nestor E. Reyes del Valle:\nOn November 13-15 & 19, 2024, and December 6, 2024, the United States Food and Drug Administration (FDA) conducted an inspection of your shell egg farm and egg processing facility, where your shell eggs are washed and packed, located at Rd. 956, Km 10.0, Bo. Guzman Arriba, Rio Grande, PR 00745. During the inspection of your farm, FDA investigators observed serious violations of the Prevention of Salmonella Enteritidis (SE) in Shell Eggs During Production, Storage, and Transportation regulation (the Shell Egg regulation), Title 21, Code of Federal Regulations, Part 118 (21 CFR Part 118). At the conclusion of the inspection, FDA investigators issued an FDA Form 483 (FDA-483), Inspectional Observations, listing deviations found at your farm.\nBased on FDA’s inspectional findings, we have determined that the shell eggs produced on your farm do not comply with the provisions of 21 CFR Part 118. Failure to comply with the provisions of 21 CFR Part 118 causes your shell eggs to be in violation of section 361(a) of the Public Health Service Act (the PHS Act), 42 U.S.C. § 264(a). In addition, these violations render your shell eggs adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. § 342(a)(4), in that they have been prepared, packed, or held under insanitary conditions whereby they may have become contaminated with filth, or whereby they may have been rendered injurious to health. You may find the FD&C Act, the PHS Act and the Shell Egg regulation through links on FDA’s home page at www.fda.gov.\nWe received your response to the FDA-483 via email on December 20, 2024, which described corrective actions taken or planned by your farm. Based on our review of the inspectional findings and your response, we are issuing this letter to advise you of FDA’s continuing concerns and to provide detailed information describing the findings at your farm.\nYour significant violations are as follows:\nShell Egg Regulation (21 CFR Part 118)\n1. You did not have and implement a written SE Prevention Plan that includes, at a minimum, the SE prevention measures required by 21 CFR 118.4. You did not have a written SE Prevention Plan for the approximate (b)(4) layers on your farm. Your written response stated that an SE Prevention Plan would be finalized between December 2024 and January 2025. To date, we have not received a written SE Prevention Plan. You are required to have an SE Prevention Plan that includes, at a minimum, the SE prevention measures outlined in 21 CFR 118.4 (a) – (e), which include:\na. Pullets\nA written SE Prevention Plan must include, among other things, the required SE prevention measures relating to pullets. Under 21 CFR 118.4(a), these measures include procuring pullets that are SE monitored or raising pullets under SE monitored conditions. Under 21 CFR 118.4(a)(1), “SE monitored” means that chicks are procured from SE-monitored breeder flocks that meet the National Poultry Improvement Plan’s (NPIP) standards for “U.S. S. Enteritidis Clean” status (9 CFR 145.23(d)) or an equivalent standard. Under 21 CFR 118.4(a)(2), “SE monitored” also means that the pullet environment is tested for SE when pullets are 14-16 weeks of age.\nYour farm received a primary flock of (b)(4) chicks on April 30, 2024, followed by a secondary flock of (b)(4) chicks on May 7, 2024. We acknowledge you provided a NPIP Form for the flock of chicks you procured from your supplier on May 7, 2024, but you did not provide documentation for the chicks received on or around April 30, 2024. Furthermore, you did not conduct the required SE environmental test for both flocks at 14-to-16 weeks of age, as required by 21 CFR 118.4(a)(2)(i).\nYour written response stated that you will schedule for future flocks to be tested for SE between 14-16 weeks of age by a licensed professional. However, as discussed above, we have not received a written SE Prevention Plan that describes these measures. We also note that your written response stated, as part of your firm’s corrective actions, that FDA swabbed poultry house (b)(4) on November 19, 2024, with subsequent negative results. The layers were approximately (b)(4) weeks of age when FDA conducted this sampling. This does not constitute a corrective action and should not be viewed as such.\nb. Biosecurity\nA written SE Prevention Plan must include, among other things, the required SE prevention measures relating to biosecurity, as stated in 21 CFR 118.4(b). That provision requires you to take steps to ensure that there is no introduction or transfer of SE into or among poultry houses. These biosecurity measures must include, at a minimum:\nLimiting visitors on the farm and in the poultry houses (21 CFR 118.4(b)(1));\nMaintaining practices that will protect against cross contamination when equipment is moved among poultry houses (21 CFR 118.4(b)(2));\nMaintaining practices that will protect against cross contamination when persons move between poultry houses (21 CFR 118.4(b)(3));\nPreventing stray poultry, wild birds, cats, and other animals from entering poultry houses (21 CFR 118.4(b)(4)); and\nNot allowing employees to keep birds at home (21 CFR 118.4(b)(5)).\nAs discussed above, you did not have a written SE Prevention Plan to address these measures. Furthermore, visitors’ access to the facility was not limited and, despite your indication on November 13, 2024, that individuals enter the facility to pick up or distribute eggs every other day, our investigators identified August 20, 2024, as the last date a pickup was registered in your entry log. Additionally, for poultry house (b)(4), FDA investigators observed there was no entry door to limit access and the house had damaged or missing netting and gaps within the cement structure. Numerous wild birds located inside the poultry house above layers in cages, in walkways, and eating directly from feed trays. Wild birds were also observed in the manure pits, and along the perimeter of your exposed house. Furthermore, cats and several species of reptiles were also observed in the manure pit and surrounding the poultry house.\nWe acknowledge your written response, in which you state you are now restricting visitor access to the farm through signs, and that you have implemented a visitor log and provided employee training. You also described how you will prevent stray animals from entering the poultry houses by adding physical barriers. You state your poultry houses are under construction, which you expect to be completed by June 2025. However, your written response lacks supporting detail to further assess how you will implement these corrective actions and practices. Additionally, you did not provide an SE Prevention Plan to describe any biosecurity steps.\nc. Rodents, Flies, and Other Pest Control\nA written SE Prevention Plan must include, among other things, the required rodent, fly, and other pest control measures as stated in 21 CFR 118.4(c). As discussed above, you did not have a written SE Prevention Plan to address these measures. Furthermore, you were not monitoring for the presence of rodents and flies by appropriate monitoring methods, as required by 21 CFR 118.4(c)(1) and 21 CFR 118.4(c)(2), nor did you remove debris within a poultry house and vegetation and debris outside the poultry house that may provide harborage for pests, as required by 21 CFR 118.4(c)(3).\nSpecifically, for rodents, you stated you receive monthly services by a subcontractor; however, there were no pest control records available for review. Additionally, FDA investigators observed multiple rodent bait stations for poultry house (b)(4) that were broken and\u002For did not contain bait. For flies, you did not have any monitoring or control measures in place, and FDA investigators also observed flies too numerous to count inside the poultry house that were in direct contact with hens, eggs, and chicken feed. Furthermore, FDA investigators observed harborage for pests in and outside of your poultry house. This included excessive amounts of accumulated trash and debris, stagnant water, piles of broken eggs, and spilled chicken feed. Also, multiple deceased layers were observed inside poultry house (b)(4), with two of the deceased birds having their heads in direct contact with the egg belt, causing the eggs to get jammed.\nYour written response acknowledged that rodents were not being monitored appropriately and stated that the rodent monitoring and bait stations have been installed and updated, more rodent bait stations have been added around buildings, professional pest control services have been engaged, and that you have cleaned and removed debris that may attract rodents. Furthermore, your response acknowledged that the presence of flies was not being appropriately monitored and stated that fly monitoring systems have been updated. Additionally, you stated potential pest harborage sites inside and outside the poultry houses have been eliminated. However, your response did not provide an SE Prevention Plan or provide supporting details to assess whether the corrective actions were adequate. Please note that in addition to describing appropriate monitoring methods for rodents and flies, a written SE Prevention Plan must also address the requirement that when monitoring indicates unacceptable rodent or fly activity within a poultry house, you must use appropriate methods to achieve satisfactory rodent\u002Ffly control.\nd. Cleaning and Disinfection\nA written SE Prevention Plan must include, among other things, cleaning and disinfection procedures for the poultry house, as stated in 21 CFR 118.4(d). You must clean and disinfect the poultry house according to these procedures before new laying hens are added to the house, if you have had an environmental test or an egg test that was positive for SE at any point during the life of a flock that was housed in the poultry house prior to depopulation.\nAs discussed above, you did not have a written SE Prevention Plan. Your written response states that you are developing a written SE Prevention Plan that will include, among other things, cleaning and disinfection protocols. However, as discussed above, you still have not provided a written SE Prevention Plan.\ne. Refrigeration\nYou did not hold eggs at or below 45°F ambient temperature beginning 36 hours after time of lay, nor do you have a written SE Prevention Plan including these refrigeration requirements, as required by 21 CFR 118.4(e). For example:\nOn November 14, 2024, your two analog thermometers located at the back and entrance of the cooler read (b)(4)°-(b)(4)°F, while FDA’s calibrated thermometer read 52°-58°F. On November 14, 2024, the same two analog thermometers read between (b)(4)°-(b)(4)°F, while the FDA calibrated thermometer read 58.8°F.\nOn November 15, 2024, your two thermometers at the entrance of the cooler read (b)(4)°F (digital) \u002F (b)(4)°F (analog), while the FDA calibrated thermometer read 46.5°F.\nOn November 19, 2024, your two thermometers at the entrance of the cooler read (b)(4)°F (digital) \u002F (b)(4)°F (analog), while the FDA calibrated thermometer read 51.9°F\nWe acknowledge your written response, in which you state that “(b)(4).” You stated (b)(4). However, your response did not provide an SE Prevention Plan or provide supporting details to assess whether the corrective actions were adequate.\n2. You have never registered your egg farm with FDA, as required by 21 CFR 118.11(a).\nYour written response states that you registered your farm with FDA by December 6, 2024; however, we do not have a record of your registration.\nFederal Food, Drug, and Cosmetic Act (FD&C Act)\nYour eggs were prepared, packed, or held under insanitary conditions whereby they may have become contaminated with filth or rendered injurious to health within the meaning of section 402(a)(4) of the FD&C Act. Specifically, during the inspection, our investigators observed the following insanitary conditions and practices at your farm during the processing of shell eggs:\nFDA investigators observed too numerous to count dead flies inside the (b)(4)-gallon water tank of the egg washer and lying on the surface of the egg washer. Flies were also observed inside the packaging room on top of washed eggs.\nThe conveyor belt connecting poultry house (b)(4) to the egg washing\u002Fpackaging room was uncovered, outside of any building structure. FDA investigators observed that the eggs held on this conveyor belt are continuously exposed to the environment and to pests and other animals, including flying insects, reptiles, cats, and wild birds, for up to (b)(4) hours (because collection and packaging operations are conducted every other day).\nFurthermore, you did not follow the disinfectant manufacturer’s instructions in preparing the disinfectant solution for the eggs by using the correct amount of disinfectant within the (b)(4)-gallon water tanks. You stated that (b)(4) oz. of disinfectant is used for the (b)(4)-gallon tank of the washing machine, instead of the 22.5 oz. directed by the manufacturer’s instructions of 0.5 oz per gallon.\nYour written response stated that a monitoring program has been established to inspect conveyor belts and poultry houses daily. Furthermore, you stated your employees were not properly trained on the manufacturer’s instructions for the appropriate level of disinfectant. As your corrective actions, you state you have retrained your employees on the proper preparation of the disinfectant and revised your procedures and displayed them near the egg washer. Furthermore, your written response stated you have cleaned the washer, have implemented a daily cleaning and inspection schedule to ensure consistent hygiene, and introduced a new maintenance log for documenting cleaning and sanitation activities. You have not provided additional supporting details in order for us to fully evaluate these corrective actions.\nThis letter is not intended to be an all-inclusive statement of the violations that may exist at your farm or in connection with your shell eggs. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your shell egg production practices are conducted in compliance with federal law, including the FD&C Act, the PHS Act, and the Shell Egg regulation.\nThis letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in legal action including, without limitation, seizure, injunction, or the initiation of administrative enforcement procedures under 21 CFR 118.12(a).\nAdditional Comment\nRecords are an important component to ensure your compliance with FDA’s Shell Egg regulation. 21 CFR 118.10 describes the records required for your SE Prevention Plan and other general recordkeeping requirements. We encourage you to review these requirements when working to develop and implement your SE Prevention Plan and environmental testing procedures. Please note that resources are also available on our website at www.fda.gov\u002Feggs that address various aspects of shell egg regulation, including some of the topics addressed in this letter. For example, the December 2011 Guidance for Industry “Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation” and the July 2015 Guidance for Industry “Questions and Answers Regarding the Final Rule, Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation” provide answers to common questions about the Shell Egg regulation.\nPlease notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective actions within 15 working days, state the reason for the delay and the time within which you will do so. If you believe that you have complied with pertinent laws and regulations, include your reasoning and any supporting information for our consideration.\nPlease send your reply via email to: HFP-OCE-ConventionalFoods@fda.hhs.gov, copying Lisa Thursam, Compliance Officer, at Lisa.Thursam@fda.hhs.gov or by hardcopy to Food and Drug Administration, Attention: Lisa Thursam, Compliance Officer, Human Foods Program – Office of Compliance and Enforcement, Office of Enforcement – Division of Conventional Foods Enforcement (HFS-607), 5001 Campus Drive, College Park, MD 20740 U.S.A. If you have any questions regarding any issues in this letter, please contact Lisa Thursam, Compliance Officer, via email at Lisa.Thursam@fda.hhs.gov. Please include CMS reference #701874 on any submissions and within the subject line of any email correspondence to the agency.\nSincerely,\n\u002FS\u002F\nMaria S. Knirk, J.D., M.B.A.\nActing Director, Office of Enforcement\nOffice of Compliance and Enforcement\nHuman Foods Program\nFood and Drug Administration","Nestor Reyes Farm & Associates","nestor-reyes-farm-associates-701874-08212025","2026-08-18T06:42:28.676509+00:00","https:\u002F\u002Fwww.fda.gov\u002Finspections-compliance-enforcement-and-criminal-investigations\u002Fwarning-letters\u002Fnestor-reyes-farm-associates-701874-08212025","2026-10-26T08:09:31.916283+00:00","Issued","2025-09-30","701874","Mr. Nestor E. Reyes del Valle","2026-08-19T16:16:25.355+00:00","Via Email","2025-08-21",2,{"510k":58,"classification":59,"enforcement":60,"event":61,"event_backfill":62,"pma":63,"warning_letter":64},"2026-11-16T02:00:55.89+00:00","2026-11-16T02:00:41.999+00:00","2026-11-16T02:00:49.415+00:00","2026-11-17T04:00:34.414+00:00","2026-09-07T05:17:28.839+00:00","2026-11-16T02:01:03.155+00:00","2026-11-17T01:02:55.859+00:00"]